Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289198 · ClinicalTrials.gov registry record · Phase 3
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
A Phase 3 study of Rhinitis, Allergic, Perennial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 301
- Enrollment target
- 20
- Study locations
NCT00289198 is a Phase 3 study of Rhinitis, Allergic, Perennial that has completed, run by GlaxoSmithKline. The registered enrollment target is 301 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT00289198, a Phase 3 study of Rhinitis, Allergic, Perennial, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 301 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG FF
Study Locations (20)
Victoria
- GSK Investigational Site - Clayton
- GSK Investigational Site - Melbourne
- GSK Investigational Site - Parkville
Ontario
- GSK Investigational Site - Mississauga
- GSK Investigational Site - Ottawa
- GSK Investigational Site - Toronto
Maryland
- GSK Investigational Site - Baltimore
- GSK Investigational Site - Wheaton
California
- GSK Investigational Site - San Diego
Massachusetts
- GSK Investigational Site - North Dartmouth
Minnesota
- GSK Investigational Site - Minneapolis
Ohio
- GSK Investigational Site - Canton
Rhode Island
- GSK Investigational Site - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2006-02-07 |
| Est. Completion | 2006-07-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289198
The ClinicalTrials.gov registry entry for NCT00289198 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhinitis, Allergic, Perennial appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00289198 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Victoria, Ontario, Maryland.
Frequently Asked Questions
What is clinical trial NCT00289198 about?
NCT00289198 is a clinical study titled "Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)". The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).
What is the current status of trial NCT00289198?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 301 participants. The study started on 2006-02-07. Estimated completion is 2006-07-04.
What conditions does trial NCT00289198 study?
This clinical trial studies the following conditions: Rhinitis, Allergic, Perennial.
What interventions are being tested in trial NCT00289198?
The interventions under investigation include: Placebo (DRUG), FF (DRUG).
Who is sponsoring clinical trial NCT00289198?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00289198 being conducted?
This trial has 20 study locations across California, Maryland, Massachusetts, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhinitis, Allergic, Perennial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.